Van Oene Mark
- SEC CIK
- 0001707477
In the past year, 3 open-market sale filings worth $335.1K and no purchases.
Current role at each company
- PACB Pacific Biosciences of California, Inc.See Remarksas of Aug 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $335.1K
- 3 filings
- Net
- −$335.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Van Oene Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)8:17 PM ET | Aug 17 | 1 day | Van Oene MarkSee Remarks | SSale | −26.9K | $1.13 | −$30.4K | −1.0%2.71M after | |
| Mar 4, 2026 (view filing) | Mar 3 | 1 day | Van Oene MarkSee Remarks | SSale | −6.50K | $1.51 | −$9.82K | −0.3%2.24M after | |
| Feb 19, 2026 (view filing) | Feb 17-18 | 2 days | Van Oene MarkSee Remarks | SSale | −184.9K | $1.59 | −$294.9K | −9.6%1.74M after | 2 lots |
| Aug 20, 2025 (view filing) | Aug 18 | 2 days | Van Oene MarkSee Remarks | SSale | −26.8K | $1.31 | −$35.2K | −1.4%1.92M after | |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Van Oene MarkSee Remarks | SSale | −6.49K | $1.41 | −$9.15K | −0.4%1.50M after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Van Oene MarkSee Remarks | SSale | −100.8K | $1.88 | −$189.5K | −6.3%1.50M after | |
| Jan 10, 2025 (view filing) | Jan 10 | Same day | Van Oene MarkSee Remarks | SSale | −34.4K | $2.03 | −$69.8K | −2.1%1.60M after | |
| Aug 20, 2024 (view filing) | Aug 16 | 4 days | Van Oene MarkSee Remarks | SSale | −38.0K | $1.66 | −$63.1K | −2.3%1.63M after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Van Oene MarkSee Remarks | SSale | −9.19K | $4.87 | −$44.7K | −0.5%1.67M after | |
| Feb 21, 2024 (view filing) | Feb 16 | 5 days | Van Oene MarkSee Remarks | SSale | −33.6K | $5.96 | −$200.0K | −3.7%876.6K after | |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Van Oene MarkSee Remarks | SSale | −31.0K | $7.77 | −$241.0K | −3.3%910.2K after | |
| Aug 18, 2023 (view filing) | Aug 16 | 2 days | Van Oene MarkSee Remarks | SSale | −26.1K | $11.00 | −$287.1K | −2.7%939.8K after | |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Van Oene MarkSee Remarks | SSale | −6.27K | $9.49 | −$59.5K | −0.6%965.9K after | |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Van Oene MarkSee Remarks | SSale | −26.7K | $9.53 | −$254.7K | −4.0%640.8K after | |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Van Oene MarkChief Operating Officer | SSale | −41.5K | $14.23 | −$590.3K | −12.4%293.5K after |